CytoMed Therapeutics
(NASDAQ) GDTC
CytoMed Therapeutics Financials at a Glance
Market Cap
$12.32M
Revenue (TTM)
$366.78K
Net Income (TTM)
$3.35M
EPS (TTM)
$-0.24
P/E Ratio
-4.37
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.00
Volume
0
Open
$1.01
Price
$1.00
Volume
0
Open
$1.01
Previous Close
$1.00
Daily Range
$1.00 - $1.01
52-Week Range
$0.73 - $3.68
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.00
Volume
0
Open
$1.01
Previous Close
$1.00
Daily Range
$1.00 - $1.01
52-Week Range
$0.73 - $3.68
GDTC News
GDTC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CytoMed Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
43
CEO
Wee Kiat Tan, PhD
Website
www.cytomed.sgHeadquarters
Singapore, 149544, SG
GDTC Financials
Key Financial Metrics (TTM)
Gross Margin
1%
Operating Margin
-7%
Net Income Margin
-9%
Return on Equity
-42%
Return on Capital
-44%
Return on Assets
-51%
Earnings Yield
-22.88%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.32M
Shares Outstanding
11.73M
Volume
0
Short Interest
0.00%
Avg. Volume
593.56K
Financials (TTM)
Gross Profit
$52.38K
Operating Income
$2.63M
EBITDA
$1.79M
Operating Cash Flow
$1.98M
Capital Expenditure
$1.03M
Free Cash Flow
$3.01M
Cash & ST Invst.
$3.64M
Total Debt
$339.20K
CytoMed Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$105.70K
+27.9%
Gross Profit
$98.38K
+20.2%
Gross Margin
93.07%
N/A
Market Cap
$12.32M
N/A
Market Cap/Employee
$286.52K
N/A
Employees
43
N/A
Net Income
$882.30K
-9.2%
EBITDA
$804.32K
-16.8%
Quarterly Fundamentals
Net Cash
$1.86M
-60.6%
Accounts Receivable
$965.91K
N/A
Inventory
$0.00
-100.0%
Long Term Debt
$339.56K
+17.8%
Short Term Debt
$45.48K
+65.0%
Return on Assets
-50.97%
N/A
Return on Invested Capital
-43.57%
N/A
Free Cash Flow
$765.59K
-0.5%
Operating Cash Flow
$628.83K
-47.5%